Skip to content
2000
Volume 14, Issue 4
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

Peripheral artery disease (PAD) is a highly prevalent disease, which still has unmet medical needs. Therapeutic angiogenesis for PAD, achieved by gene therapy, has achieved promising results in preclinical studies and early-phase clinical trials, yet few late-phase clinical trials have been conducted or have not shown efficacy. This article provides an overview of the progression of angiogenesis research in gene therapy field as it applies to PAD. The focus of angiogenic growth factors and clinical trials is introduced as a frontier of therapeutic angiogenesis. The article also includes insights into future directions from bench to bedside.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/156652321404140902124838
2014-08-01
2025-06-25
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/156652321404140902124838
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test